SSkFca5NoXQpboevjHgRS6qn6IcnzVC9QvNvCIqW

Breakthrough In Sickle Cell Disease: FDA Approves First Gene Therapies as Potential Cure for the Condition

For as long as it was first described in 1910, a cure for sickle cell disease had evaded experts in the medical world. All that changed this past Friday when the Food and Drug Administration (FDA) gave a nod to two revolutionary treatments for the disease. In a milestone announcement, the agency approved Casgevy and Lyfgenia as the world’s first gene editing therapies and potential cures for sickle cell disease.